Published in Women's Health Weekly, September 8th, 2005
The Saskatchewan compounds appear to be highly potent chemopotentiators, drugs that enhance the activities of existing chemotherapeutic treatments. They are protected by three sets of intellectual property and have demonstrated activity in cancer, neurological and other degenerative diseases.
It is YM's intention to focus its own resources on the oncology applications and seek partners in order to advance these compounds in neurological...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly